Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared some papers on X:
“Lung cancer in never smokers: from early detection to prevention – Nice review on this by Charles Swanton and colleagues.
Lung cancer in never smokers (LCINS) now accounts for a growing proportion of lung cancer cases, with distinct demographics and biology. Identifying risk factors for LCINS remains challenging. The most well-established factors—germline variants, clonal hematopoiesis, and environmental exposures—currently lack validated screening tests.”
Title: Lung cancer in never smokers: from early detection to prevention
Authors: Deborah Caswell, Crispin Hiley, Cian Murphy, Loc Carlo Bao, Charles Swanton
Read the Full Article.
More posts featuring Vivek Subbiah.
